32 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

  • Bionano Genomics, Inc. BNGO stock surged 34.1% to $1.85 during Friday's pre-market session. The market value of their outstanding shares is at $7.6 million.
  • Nuvectra, Inc. NVTR stock increased by 26.9% to $1.89. The market value of their outstanding shares is at $25.5 million.
  • AzurRx BioPharma, Inc. AZRX stock rose 14.1% to $0.89. The market cap seems to be at $15.6 million. The most recent rating by H.C. Wainwright, on September 26, is at Buy, with a price target of $5.00.
  • Fluidigm, Inc. FLDM stock moved upwards by 12.5% to $4.85. The market value of their outstanding shares is at $321.3 million. The most recent rating by UBS, on October 18, is at Buy, with a price target of $7.00.
  • Check-Cap, Inc. CHEK shares surged 8.8% to $1.74. The market cap seems to be at $15.4 million.
  • Xenetic Biosciences, Inc. XBIO stock surged 8.2% to $1.46. The market cap seems to be at $6.5 million.
  • Redhill Biopharma, Inc. RDHL stock rose 7.8% to $6.65.
  • Endo International, Inc. ENDP stock rose 6.8% to $5.16. The market value of their outstanding shares is at $715.3 million.
  • Mallinckrodt, Inc. MNK stock surged 5.9% to $2.71. The market cap stands at $202.4 million. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
  • Marinus Pharmaceuticals, Inc. MRNS stock surged 4.5% to $1.39. The market cap seems to be at $66.7 million. The most recent rating by H.C. Wainwright, on September 03, is at Buy, with a price target of $5.00.
  • Dynavax Technologies, Inc. DVAX shares rose 4.5% to $4.43. The market cap seems to be at $374.0 million. The most recent rating by HC Wainwright & Co., on October 18, is at Buy, with a price target of $13.00.
  • Foamix Pharmaceuticals, Inc. FOMX shares rose 4.3% to $3.38. The market cap stands at $185.4 million.
  • Titan Pharmaceuticals, Inc. TTNP stock rose 4.1% to $0.17. The market cap seems to be at $4.2 million.
  • Clovis Oncology, Inc. CLVS shares rose 3.8% to $3.80. The market value of their outstanding shares is at $233.3 million. The most recent rating by Goldman Sachs, on October 08, is at Sell, with a price target of $3.00.
  • Guardion Health Sciences, Inc. GHSI shares increased by 3.7% to $0.51. The market cap seems to be at $28.3 million.
  • Invitae, Inc. NVTA stock rose 3.3% to $18.88. The market value of their outstanding shares is at $1.9 billion.
  • Rigel Pharmaceuticals, Inc. RIGL shares rose 3.1% to $1.65. The market cap seems to be at $284.9 million. The most recent rating by JP Morgan, on September 26, is at Overweight, with a price target of $7.00.
  • Arrowhead Pharmaceuticals, Inc. ARWR shares rose 3.0% to $37.69. The market cap stands at $2.6 billion. The most recent rating by Baird, on October 03, is at Outperform, with a price target of $39.00.
  • CannTrust Holdings, Inc. CTST stock rose 2.9% to $1.40. The market cap seems to be at $223.0 million.
  • Ekso Bionics Holdings, Inc. EKSO stock rose 2.9% to $0.59. The market cap stands at $37.8 million. The most recent rating by Cantor Fitzgerald, on September 06, is at Overweight, with a price target of $1.00.
  • Melinta Therapeutics, Inc. MLNT stock moved upwards by 2.5% to $4.49. The market value of their outstanding shares is at $48.6 million. According to the most recent rating by H.C. Wainwright, on August 12, the current rating is at Neutral.
  • Conatus Pharmaceuticals, Inc. CNAT stock rose 2.4% to $0.39. The market value of their outstanding shares is at $11.2 million.
  • Cronos Group, Inc. CRON shares rose 2.4% to $9.07. The market cap seems to be at $4.0 billion. The most recent rating by Piper Jaffray, on August 13, is at Overweight, with a price target of $18.00.
  • Innate Pharma, Inc. IPHA stock surged 1.6% to $6.15.
  • Aphria, Inc. APHA stock surged 1.5% to $4.98. The market cap seems to be at $1.7 billion. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.

 

Losers

  • Hepion Pharmaceuticals, Inc. HEPA stock decreased by 9.8% to $3.23 during Friday's pre-market session. The market cap stands at $9.3 million.
  • Ocugen, Inc. OCGN stock plummeted 4.4% to $1.74. The market cap seems to be at $4.4 million.
  • DBV Technologies, Inc. DBVT shares plummeted 3.7% to $7.57.
  • Viveve Medical, Inc. VIVE stock fell 2.7% to $4.67. The market value of their outstanding shares is at $2.6 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • Cancer Genetics, Inc. CGIX shares plummeted 1.7% to $0.15. The market cap stands at $6.1 million.
  • Galapagos, Inc. GLPG shares fell 1.5% to $160.50. The most recent rating by Morgan Stanley, on September 10, is at Overweight, with a price target of $200.00.
  • ProQR Therapeutics, Inc. PRQR stock decreased by 1.3% to $6.70. The market cap stands at $238.9 million.

Posted In: Healthcare Stocks Pre-Market MoversTop GainersNewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.